Our study found that GXYLT2 knockdown did not affect the levels of cleaved Notch1 and its downstream target genes, indicating that novel substrates or the glycotransferase activity-independent functions of GXYLT2 should be further explored in GC cells. The gene discussed is NOTCH1; the disease is gastric cancer.